These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2100158)
21. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements. Alder HC Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209 [TBL] [Abstract][Full Text] [Related]
22. Screening for potential in vivo phototoxicity in the lens/retina. Roberts JE; Dillon J Lens Eye Toxic Res; 1990; 7(3-4):655-66. PubMed ID: 2100184 [TBL] [Abstract][Full Text] [Related]
24. Benefit and risk of organic ultraviolet filters. Nohynek GJ; Schaefer H Regul Toxicol Pharmacol; 2001 Jun; 33(3):285-99. PubMed ID: 11407932 [TBL] [Abstract][Full Text] [Related]
25. Intracameral antibiotics: questions for the United States based on prospective studies. Liesegang TJ J Cataract Refract Surg; 2008 Mar; 34(3):505-9. PubMed ID: 18299079 [TBL] [Abstract][Full Text] [Related]
26. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
27. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs. Waltman SR; Kaufman HE Invest Ophthalmol; 1970 Apr; 9(4):250-5. PubMed ID: 5435768 [No Abstract] [Full Text] [Related]
28. Regulatory aspects of contact lenses. Halberg GP Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(3):OP419-22. PubMed ID: 4837458 [No Abstract] [Full Text] [Related]
30. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective. Wright C; Schnoll S; Bernstein D Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964 [TBL] [Abstract][Full Text] [Related]
31. Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development. Brock WJ; Somps CJ; Torti V; Render JA; Jamison J; Rivera MI Int J Toxicol; 2013; 32(3):171-88. PubMed ID: 23616147 [TBL] [Abstract][Full Text] [Related]
32. [Requirements for the toxicological testing of new pesticides and agents for controlling biological processes]. Beitz H Arch Exp Veterinarmed; 1979 Jan; 33(1):121-8. PubMed ID: 454086 [TBL] [Abstract][Full Text] [Related]
33. Contact lenses -- past, present, future. Davis HE J Am Optom Assoc; 1979 Mar; 50(3):278. PubMed ID: 448004 [No Abstract] [Full Text] [Related]
35. New standards and procedures for intraocular lenses. FDA Drug Bull; 1978; 8(1):4. PubMed ID: 580245 [No Abstract] [Full Text] [Related]
36. [Intraocular penetration of ophthalmic drugs of different molecular weight and their elution from hydrophilic contact lenses]. Krejcí L; Praus R Cesk Oftalmol; 1977 Mar; 33(2):97-102. PubMed ID: 849618 [No Abstract] [Full Text] [Related]
37. The FDA role in contact lens development and safety. Lippman RE Cornea; 1990; 9 Suppl 1():S64-7; discussion S68. PubMed ID: 2189684 [TBL] [Abstract][Full Text] [Related]
39. Novelty contact lenses are banned in the United States. Josefson D BMJ; 2002 Nov; 325(7371):990. PubMed ID: 12420329 [No Abstract] [Full Text] [Related]